Acetazolamide Terminated Phase 3 Trials for Central Apnea / Heart Failure Basic Science

IndicationsStatusPurposePhase
TerminatedBasic Science3
clinicaltrials.gov IdentifierTitleDrugs
NCT00746954Buspirone as a Potential Treatment for Recurrent Central Apnea